Experimental Metastasis: Modeling And Analysis
Published 2013 · Medicine
Download PDFAnalyze on Scholarcy
Only for you today! Discover your favourite experimental metastasis modeling and analysis book right here by downloading and getting the soft file of the book. This is not your time to traditionally go to the book stores to buy a book. Here, varieties of book collections are available to download. One of them is this experimental metastasis modeling and analysis as your preferred book. Getting this book b on-line in this site can be realized now by visiting the link page to download. It will be easy. Why should be here?
This paper references
LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.
A. P. Lillis (2008)
Pattern of secondary genomic changes in pancreatic tumors of Tgf alpha/Trp53+/- transgenic mice.
B. Schreiner (2003)
Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer
S. Yachida (2010)
Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer.
M. Vrancken Peeters (1996)
Molecular control of lymphatic metastasis.
M. Achen (2008)
Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells.
T. Enomoto (2006)
Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
A. I. Garbe (2006)
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
P. Campbell (2010)
Murine bioluminescent hepatic tumour model.
Simon Rajendran (2010)
Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
D. Palmieri (2009)
Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12
D. Zaharoff (2010)
Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice
N. Habbe (2008)
Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells.
A. Albig (2004)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
K. Behrns (2012)
Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
W. Pardridge (2008)
Theranostic nanoshells: from probe design to imaging and treatment of cancer.
R. Bardhan (2011)
Comparison of ras-responsive gene enhancers in pancreatic tumor cells that express either wild-type or mutant K-ras.
Phillip J. Wilder (2009)
VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites.
S. Hirakawa (2007)
Dual-color imaging of nuclear-cytoplasmic dynamics, viability, and proliferation of cancer cells in the portal vein area.
K. Tsuji (2006)
Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
V. Grote (2011)
Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy
Marc-André Bellavance (2008)
Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma.
J. Morton (2010)
The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications
Jonathan P. Sleeman (2012)
Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome
K. Olive (2004)
In vivo imaging in cancer.
J. Condeelis (2010)
PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas
Pramila Ramani (2012)
An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma
C. Jacobs (2011)
Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas
M. Lieber (1975)
Effect of anti-fibrinolytic therapy on experimental melanoma metastasis
Jennifer M. Kirstein (2008)
Experimental models to study lymphatic and blood vascular metastasis
L. Chen (2011)
The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation.
S. Ramanan (2009)
Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes
H. Immervoll (2006)
Nanoparticle therapeutics: an emerging treatment modality for cancer
M. Davis (2008)
Wound-induced tumor progression: a probable role in recurrence after tumor resection.
S. Hofer (1998)
Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.
T. Corbett (1984)
Do all roads lead to Rome? Routes to metastasis development
J. Sleeman (2011)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
K. Olive (2009)
Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
Kyoko Kojima (2007)
Imaging single mammalian cells with a 1.5 T clinical MRI scanner.
Paula Foster-Gareau (2003)
The effects of surgery on tumor growth: a century of investigations.
R. Demicheli (2008)
Animal models of bone metastasis
Thomas J. Rosol (2004)
Advances in Brief The Mutant Kras Oncogene Causes Pancreatic Periductal Lymphocytic Infiltration and Gastric Mucous Neck Cell Hyperplasia in Transgenic Mice 1
F. Brembeck (2003)
Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer.
F. Skoulidis (2010)
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.
A. Aguirre (2003)
Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis.
J. Hood (2011)
Correlation between lymphangiogenesis and clinicopathological parameters in renal cell carcinoma.
Ilyas Ozardili (2012)
Loss of fibulin-5 binding to β1 integrins inhibits tumor growth by increasing the level of ROS
Marie K. Schluterman (2010)
Tumor lymphangiogenesis and melanoma metastasis
Matthias Rinderknecht (2008)
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
M. Tascilar (2001)
Development of an Orthotopic Model of Invasive Pancreatic Cancer in an Immunocompetent Murine Host
W. Tseng (2010)
TGF alpha transgenic mice. A model of pancreatic cancer development.
F. Greten (2001)
Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model
H. Ishizaki (2010)
Motexafin gadolinium: a novel radiosensitizer for brain tumors
Dave B Francis (2009)
The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer
V. Fendrich (2009)
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.
N. Bardeesy (2006)
Nanocarriers as an emerging platform for cancer therapy
S. Wise (2007)
Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery
Albert Lo (2008)
Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
J. Lee (2011)
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
A. Blackford (2009)
Induction of Th17 Cells in the Tumor Microenvironment Improves Survival in a Murine Model of Pancreatic Cancer
Jennifer L. Gnerlich (2010)
Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma
P. Mazur (2010)
Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma
J. Lee (2007)
Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
S. Arnold (2012)
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
Kamel Izeradjene (2007)
The Use of Targeted Mouse Models for Preclinical Testing of Novel Cancer Therapeutics
K. Olive (2006)
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer1
M. Tan (2009)
Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer
G. Feldmann (2008)
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
P. H. Thaker (2006)
Radiation sensitization with redox modulators: a promising approach.
A. Rosenberg (2006)
Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors
S. Emanuel (2008)
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma
S. Arnold (2010)
In vivo magnetic resonance imaging of single cells in mouse brain with optical validation.
C. Heyn (2006)
Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families
E. Slater (2010)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
S. Jones (2009)
The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity
C. Pin (2001)
The lymph node as a bridgehead in the metastatic dissemination of tumors.
J. Sleeman (2000)
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
J. Gillet (2011)
Ovarian cancer mouse models: a summary of current models and their limitations
M. Fong (2009)
The distribution of secondary growths in cancer of the breast. 1889.
S. Paget (1989)
Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
K. Liby (2010)
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
H. Burris (1997)
The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors
Y. Kawaguchi (2002)
Abnormalities of tumor suppressor gene p16in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters
K. Ohtsubo (2003)
Molecular mechanisms for individualized cancer care.
J. Mansour (2008)
The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers
C. Ashley (2011)
Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies.
D. Aune (2012)
Genetic mutations associated with cigarette smoking in pancreatic cancer.
A. Blackford (2009)
Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery.
J. Kim (2008)
Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain.
B. Gril (2008)
Role of p53 mutations on survival after pancreatoduodenectomy for ductal adenocarcinoma of the pancreatic head.
G. Gazzaniga (2001)
Bioluminescent imaging: a critical tool in pre-clinical oncology research.
K. O'Neill (2010)
Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.
Sean P Dineen (2010)
In vivo detection of single cells by MRI.
E. Shapiro (2006)
Deploying Mouse Models of Pancreatic Cancer for Chemoprevention Studies
P. Grippo (2010)
The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia
C. Carrière (2007)
Tumor-derived TGF-β Mediates Conversion of CD4+Foxp3+ Regulatory T Cells in a Murine Model of Pancreas Cancer
Tricia A. Moo-Young (2009)
Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo
H. Yanagisawa (2002)
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
N. Bardeesy (2006)
BRCA2 Germline Mutations in Familial Pancreatic Carcinoma
S. Hahn (2003)
Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases.
J. Hoffmann (2009)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.
S. Hingorani (2003)
Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis
Vincent L. Morris (2004)
In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases.
M. Bouvet (2006)
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF
T. Kamijo (1997)
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma.
D. Tuveson (2006)
Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.
G. Naumov (2002)
Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer
Shi-dai Jin (2012)
Cancer spread and micrometastasis development: Quantitative approaches for in vivo models
I. Macdonald (2002)
A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease.
M. Wagner (2001)
PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines--evidence that the liver contributes to acute phase behaviour of PAI-1.
J. de Boer (1991)
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.
S. Hingorani (2005)
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Norman E. Sharpless (2001)
Isoform-Specific Upregulation of Palladin in Human and Murine Pancreas Tumors
S. Goicoechea (2010)
Cancer metastasis as a therapeutic target.
J. Sleeman (2010)
Forced Expression of MMP9 Rescues the Loss of Angiogenesis and Abrogates Metastasis of Pancreatic Tumors Triggered by the Absence of Host SPARC
S. Arnold (2008)
Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism
K. Pogue-Geile (2006)
Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver.
E. Sandgren (1993)
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
L. Muldoon (2007)
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
O. Farokhzad (2006)
In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain.
C. Heyn (2006)
Lifestyle, Occupational, and Reproductive Factors in Relation to Pancreatic Cancer Risk
A. Lo (2007)
Inactivation of Brca2 cooperates with Trp53R172H to induce invasive pancreatic ductal adenocarcinomas in mice
G. Feldmann (2011)
Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model
M. Yang (2002)
Imaging in the era of molecular oncology
R. Weissleder (2008)
This paper is referenced by
A Stochastic Model for Cancer Metastasis: Branching Stochastic Process with Settlement
Christoph Frei (2018)
The Ras effector NORE1A forms a tumor suppressor complex with BRCA1.
Nicholas Charles Nelson (2015)
Mathematical modeling for novel cancer drug discovery and development
P. Zhang (2014)
Computational modeling reveals dynamics of brain metastasis in non-small cell lung cancer and provides a tool for personalized therapy
Michael Bilous (2018)
Mathematical model of perineural tumor spread: a pilot study
Joshua J. Jacobs (2017)
Fractal dimension and universality in avascular tumor growth.
F. L. Ribeiro (2017)
Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele
Jinghai Wu (2017)
Further genetic diversification in multiple tumors and an evolutionary perspective on therapeutics
Y. Tao (2015)
Impact of tumor-parenchyma biomechanics on liver metastatic progression: a multi-model approach
Yafei Wang (2020)